BIOMARK DIAGNOSTICS INC./ CA09073K1084 /
| 2024-04-26 8:16:07 AM | Chg. +0.0030 | Volume | Bid4:41:54 PM | Ask4:59:47 PM | High | Low |
|---|---|---|---|---|---|---|
| 0.1840EUR | +1.66% | 0 Turnover: 0.0000 |
0.1980Bid Size: 10,200 | 0.2260Ask Size: 8,900 | 0.1840 | 0.1840 |
Newsfile Corp
2023-06-05
BioMark Unveils Significant Scientific Advancements from Its Leading Liquid Biopsy Technology at ASC...
Newsfile Corp
2023-01-11
BioMark Announces Update from Ongoing Clinical Trial Using Its Lung Cancer Liquid Biopsy Test as It ...
Newsfile Corp
2021-11-30
BioMark to Collaborate with Astrazeneca, Pfizer Canada and The IUCPQ Foundation in a $3.5m Project t...
Newsfile Corp
2021-11-30
BioMark participera avec Astrazeneca, Pfizer Canada et la Fondation de l'IUCPQ à un projet de 3,5 m$...
Newsfile Corp
2021-11-16
BioMark obtiens un financement pour accélérer le développement de sa technologie de biopsie liquide ...
Newsfile Corp
2021-10-18
Liquid Biopsy Company BioMark to Present at the 3rd Annual Congress of the International Society of ...
Newsfile Corp
2021-06-29
Biomark to Expand Treatment Response Trial to Advanced Lung Cancer Patients Receiving Immunotherapy
Newsfile Corp
2021-06-01
BioMark reçoit une subvention de 825 000 $ pour développer son test de biopsie liquide pour le dépis...
